100 related articles for article (PubMed ID: 7871542)
1. Biochemical and functional analysis of rat bronchoalveolar macrophages containing chemically induced phospholipid inclusions.
Waites CR; Bugelski PJ; Badger AM
Toxicol Appl Pharmacol; 1995 Feb; 130(2):316-21. PubMed ID: 7871542
[TBL] [Abstract][Full Text] [Related]
2. Separation of immunomodulatory and cholesterol-lowering activities of heterocyclic azaspiranes.
Albrightson CR; Bugelski PJ; Berkhout TA; Jackson B; Kerns WD; Organ AJ; Badger AM
J Pharmacol Exp Ther; 1995 Feb; 272(2):689-98. PubMed ID: 7853183
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agent.
Kaplan JM; Badger AM; Ruggieri EV; Olivera DL; Newman-Tarr T; Bugelski PJ
J Clin Lab Immunol; 1991 Dec; 36(4):49-58. PubMed ID: 1668843
[TBL] [Abstract][Full Text] [Related]
4. Effects of a novel azaspirane (SK&F 105685) on arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrity.
High WB; Bugelski PJ; Nichols ME; Swift BA; Solleveld HA; Badger AM
J Rheumatol; 1994 Mar; 21(3):476-83. PubMed ID: 8006892
[TBL] [Abstract][Full Text] [Related]
5. Prevention of diabetes and induction of non-specific suppressor cell activity in the BB rat by an immunomodulatory azaspirane, SK&F 106610.
Rabinovitch A; Suarez WL; Qin HY; Power RF; Badger AM
J Autoimmun; 1993 Feb; 6(1):39-49. PubMed ID: 8457285
[TBL] [Abstract][Full Text] [Related]
6. Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane.
Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW
Transplantation; 1993 Jun; 55(6):1236-43. PubMed ID: 8516808
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of phospholipases by atiprimod, a macrophage targeting antiarthritic compound.
Handler JA; Badger A; Genell CA; Klinkner AM; Kassis S; Waites CR; Bugelski PJ
Toxicol Appl Pharmacol; 1999 Aug; 159(1):9-17. PubMed ID: 10448120
[TBL] [Abstract][Full Text] [Related]
8. Phospholipidosis in the alveolar macrophage induced by cationic amphiphilic drugs.
Reasor MJ
Fed Proc; 1984 Aug; 43(11):2578-81. PubMed ID: 6745447
[TBL] [Abstract][Full Text] [Related]
9. Atiprimod (SK&F 106615), a novel macrophage targeting agent, enhances alveolar macrophage candidacidal activity and is not immunosuppressive in Candida-infected mice.
Badger AM; Handler JA; Genell CA; Herzyk D; Gore E; Polsky R; Webb L; Bugelski PJ
Int J Immunopharmacol; 1999 Mar; 21(3):161-76. PubMed ID: 10348366
[TBL] [Abstract][Full Text] [Related]
10. Effects of SK&F 105685, a novel anti-arthritic agent, on immune function in the dog.
Kaplan JM; Badger AM; Ruggieri EV; Swift BA; Bugelski PJ
Int J Immunopharmacol; 1993 Feb; 15(2):113-23. PubMed ID: 8468115
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of animal models of autoimmune disease and the induction of non-specific suppressor cells by SK&F 105685 and related azaspiranes.
Badger AM; Dimartino MJ; Talmadge JE; Picker DH; Schwartz DA; Dorman JW; Mirabelli CK; Hanna N
Int J Immunopharmacol; 1989; 11(7):839-46. PubMed ID: 2532178
[TBL] [Abstract][Full Text] [Related]
12. Induction of non-specific suppressor cells in normal Lewis rats by a novel azaspirane SK&F 105685.
Badger AM; King AG; Talmadge JE; Schwartz DA; Picker DH; Mirabelli CK; Hanna N
J Autoimmun; 1990 Aug; 3(4):485-500. PubMed ID: 2145847
[TBL] [Abstract][Full Text] [Related]
13. Antiarthritic and suppressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents.
Badger AM; Schwartz DA; Picker DH; Dorman JW; Bradley FC; Cheeseman EN; DiMartino MJ; Hanna N; Mirabelli CK
J Med Chem; 1990 Nov; 33(11):2963-70. PubMed ID: 2146392
[TBL] [Abstract][Full Text] [Related]
14. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels.
Heyneman CA; Reasor MJ
J Pharmacol Exp Ther; 1986 Jan; 236(1):55-9. PubMed ID: 3941400
[TBL] [Abstract][Full Text] [Related]
15. SK&F 105685 treatment induces suppressor cell activity and modulates cell adhesion properties in rat recipients of cardiac allografts.
Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):758-60. PubMed ID: 8094912
[No Abstract] [Full Text] [Related]
16. The effect of SK&F 105685, a novel suppressor cell-inducing compound, in the adjuvant arthritic rat.
Badger AM; Swift BA; Bugelski PJ; High WB; DiMartino MJ; Greig R
Br J Rheumatol; 1991; 30 Suppl 2():66-9. PubMed ID: 1825183
[No Abstract] [Full Text] [Related]
17. Therapeutic activity of SK&F 105685, a novel azaspirane with suppressor-cell inducing activity.
Badger AM; Swift BA
Clin Exp Rheumatol; 1993; 11 Suppl 8():S107-9. PubMed ID: 8324933
[TBL] [Abstract][Full Text] [Related]
18. Selective immunomodulatory activity of SK&F 106615, a macrophage-targeting antiarthritic compound, on antibody and cellular responses in rats and mice.
Badger AM; Newman-Tarr TM; Satterfield JL
Immunopharmacology; 1997 Aug; 37(1):53-61. PubMed ID: 9285244
[TBL] [Abstract][Full Text] [Related]
19. Induction of non-specific suppressor cells and myeloregulatory effects of an immunomodulatory azaspirane, SK&F 105685.
King AG; Olivera D; Talmadge JE; Badger AM
Int J Immunopharmacol; 1991; 13(1):91-100. PubMed ID: 1827431
[TBL] [Abstract][Full Text] [Related]
20. X-ray microanalysis of cultured alveolar macrophages with phospholipidosis.
Lee P; Kirk RG; Reasor MJ
Exp Mol Pathol; 1993 Apr; 58(2):96-104. PubMed ID: 8388333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
